Roswell Park Study Shows Venetoclax Enhances CAR T Immune Response for CLL
January 3, 2025
Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax (brand name Venclexta) works synergistically with CAR T-cell immunotherapy to combat